Investigators surveyed adolescents and young adults with self-reported ADHD to determine what proportion already engage in tolerance breaks from their medication, and how often.
Your search for major depressive disorder returned 48 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
A placebo-controlled study of smokers with MDD evaluated varenicline with vs without behavioral interventions for smoking cessation.
As early identification of symptoms and appropriate severity stratification are important for illness management, the aim of this study was to evaluate current data on markers for instability in anorexia nervosa.
This study looked at whether youth with ADHD, following 24-HMB recommendations, were less likely to have difficulty concentrating, remembering, or making decisions and making or keeping friends.
In this study, participants were followed for 2 years with the outcomes of interest being height, weight, cardiovascular health, and psychiatric outcomes.
Researchers identify 2 major risk factors for bipolar disorder in adulthood.
Investigators searched publication databases through June 2021 for studies evaluating the efficacy of group-based PTSD interventions in the pediatric setting.
In this study, participants underwent cardiorespiratory fitness (CRF) testing using the 6-minute walk test and perceived CRF was evaluated by asking participants what they thought their current aerobic fitness level was.
A study was conducted to determine the effects of switching or augmenting antidepressant therapy in adults with treatment-resistant depression.
Data about grade point averages during transitions from early, intermediate, and upper compulsory education and to vocational or university education were sourced from population-based registers in Sweden.
Researchers evaluated the effect of traumatic events, including PTSD, on treatment adherence and outcomes in eating disorders.
During the COVID-19 pandemic, ED visits for attempted suicide and suicidal ideation increased, while no clear trend in the rates of ED visit for self-harm were observed.
Patients with MDD were randomly assigned in a 1:1:1 ratio to receive 1.5 mg daily cariprazine, 3.0 mg daily cariprazine, or placebo for 6 weeks.
Seventeen samples from 13 countries were evaluated for associations between brain structural changes observed by MRI and BMI among patients with bipolar disorder and healthy controls.
Investigators designed this study to evaluate the feasibility and potential utility of a peer-led CBT-based workshop for PPD.
Patients who had treatment-naïve MDD were recruited in the US between 2007 and 2013 for the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) study.
Investigators searched publication databases for randomized controlled trials evaluating cognitive training and remediation interventions among patients with MDD.
The Alpha-Stim-D trial was a noncommercial, multicenter, randomly assigned, parallel group, double-blind trial conducted at 25 primary care practices in the United Kingdom.
Investigators searched publication databases for studies that evaluated the association between childhood maltreatment and mental health outcomes.
The REAL-ESK study was an observational, retrospective, multicenter study conducted in Italy.
Children and adolescents were evaluated for receipt of antipsychotics between 2000 and 2019 in England.
Investigators sourced data for this study from the Stockholm Major Depressive Disorder Cohort. Between 2010 and 2018, all patients in the Stockholm region who met the criteria for MDD were enrolled in the cohort.
Investigators from the Veteran’s Affairs Center for Innovation to Implementation and Stanford University searched publication databases through June 2022 for observational studies about methamphetamine-associated heart failure.
Investigators looked into which treatment fared better for patients with anxiety disorders: a mindfulness-based stress reduction intervention or escitalopram.
Researchers assessed characteristics and correlates of metabolic syndrome in adolescents with major depressive disorder or bipolar disorder depression.
Researchers examined associations between polygenic risk scores and neuropsychiatric conditions using data from phenome-wide association studies.
Researchers compared the white matter networks of patients with remitted major depressive disorder and remitted bipolar disorder to find disease-specific alterations.
Researchers evaluated the efficacy of dextromorphan-bupropion among patients with major depressive disorder and comorbid anxiety.
Researchers investigated whether lurasidone monotherapy would improve health-related quality of life.
Researchers investigated whether there were identifiable treatment-specific and shared predictors for response to pharmacotherapies for ADHD among children.